Wukui Huang
About
In The Last Decade
Wukui Huang
16 papers receiving 118 citations
Peers
Comparison fields: 5 of 20
- Molecular Biology 86
- Cancer Research 81
- Pulmonary and Respiratory Medicine 16
- Surgery 15
- Hepatology 14
Countries citing papers authored by Wukui Huang
This map shows the geographic impact of Wukui Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wukui Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wukui Huang more than expected).
Fields of papers citing papers by Wukui Huang
This network shows the impact of papers produced by Wukui Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wukui Huang. The network helps show where Wukui Huang may publish in the future.
Co-authorship network of co-authors of Wukui Huang
This figure shows the co-authorship network connecting the top 25 collaborators of Wukui Huang. A scholar is included among the top collaborators of Wukui Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wukui Huang. Wukui Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 6 | |
| 8 | 12 | |
| 9 | 16 | |
| 10 | 52 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | Metronomic S-1 chemotherapy plus transcatheter arterial chemoembolization (TACE): a promising treatment of hepatocellular carcinoma refractory to TACE. | 5 |
| 14 | S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma. | 1 |
| 15 | 6 | |
| 16 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.